566 related articles for article (PubMed ID: 26035162)
61. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
[TBL] [Abstract][Full Text] [Related]
62. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: three-dimensional computed tomography plan evaluation.
Cengiz M; Gürdalli S; Selek U; Yildiz F; Saglam Y; Ozyar E; Atahan IL
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):464-8. PubMed ID: 17768014
[TBL] [Abstract][Full Text] [Related]
63. Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique.
Nishikawa R; Yoshida K; Ebina Y; Omoteda M; Miyawaki D; Ishihara T; Ejima Y; Akasaka H; Satoh H; Kyotani K; Takahashi S; Sasaki R
J Radiat Res; 2018 May; 59(3):316-326. PubMed ID: 29518234
[TBL] [Abstract][Full Text] [Related]
64. Estimation of the total rectal dose of radical external beam and intracavitary radiotherapy for uterine cervical cancer using the deformable image registration method.
Hayashi K; Isohashi F; Akino Y; Wakai N; Mabuchi S; Suzuki O; Seo Y; Ootani Y; Sumida I; Yoshioka Y; Kimura T; Ogawa K
J Radiat Res; 2015 May; 56(3):546-52. PubMed ID: 25678538
[TBL] [Abstract][Full Text] [Related]
65. Effect of bladder distention on bladder base dose in gynaecological intracavitary high dose rate brachytherapy.
Adli M; Garipagaoglu M; Kocak Z
Br J Radiol; 2009 Mar; 82(975):243-8. PubMed ID: 19064593
[TBL] [Abstract][Full Text] [Related]
66. Late rectal toxicity determined by dose-volume parameters in computed tomography-based brachytherapy for locally advanced cervical cancer.
Zhou YC; Zhao LN; Wang N; Hu J; Sun XH; Zhang Y; Li JP; Li WW; Liu JY; Wei LC; Shi M
Cancer Med; 2016 Mar; 5(3):434-41. PubMed ID: 26806114
[TBL] [Abstract][Full Text] [Related]
67. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
[TBL] [Abstract][Full Text] [Related]
68. High-dose-rate interstitial brachytherapy with computed tomography-based treatment planning for patients with locally advanced uterine cervical carcinoma.
Saitoh J; Ohno T; Sakurai H; Katoh H; Wakatsuki M; Noda SE; Suzuki Y; Sibuya K; Takahashi T; Nakano T
J Radiat Res; 2011; 52(4):490-5. PubMed ID: 21785237
[TBL] [Abstract][Full Text] [Related]
69. Computed tomography-based three-dimensional dosimetry of intracavitary brachytherapy for cervical cancer.
Wadasaki K; Monzen Y; Kurose T; Okazaki H; Mito M
Jpn J Radiol; 2010 Dec; 28(10):740-5. PubMed ID: 21191739
[TBL] [Abstract][Full Text] [Related]
70. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
[TBL] [Abstract][Full Text] [Related]
71. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms.
Kim RY; Pareek P
Brachytherapy; 2003; 2(4):200-6. PubMed ID: 15062127
[TBL] [Abstract][Full Text] [Related]
72. Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?
Patel S; Mehta KJ; Kuo HC; Ohri N; Patel R; Yaparpalvi R; Garg MK; Guha C; Kalnicki S
Brachytherapy; 2016; 15(2):185-90. PubMed ID: 26796601
[TBL] [Abstract][Full Text] [Related]
73. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
[TBL] [Abstract][Full Text] [Related]
74. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer.
Viswanathan AN; Cormack R; Holloway CL; Tanaka C; O'Farrell D; Devlin PM; Tempany C
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):91-9. PubMed ID: 16839709
[TBL] [Abstract][Full Text] [Related]
75. Dose constraints in the rectum and bladder following carbon-ion radiotherapy for uterus carcinoma: a retrospective pooled analysis.
Okonogi N; Fukahori M; Wakatsuki M; Ohkubo Y; Kato S; Miyasaka Y; Tsuji H; Nakano T; Kamada T
Radiat Oncol; 2018 Jun; 13(1):119. PubMed ID: 29941040
[TBL] [Abstract][Full Text] [Related]
76. Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix.
Dale E; Hellebust TP; Skjønsberg A; Høgberg T; Olsen DR
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):963-71. PubMed ID: 10863066
[TBL] [Abstract][Full Text] [Related]
77. Image guided radiation therapy boost in combination with high-dose-rate intracavitary brachytherapy for the treatment of cervical cancer.
Wang X; Li J; Wang P; Yuan K; Yin G; Wan B
J Contemp Brachytherapy; 2016 Apr; 8(2):122-7. PubMed ID: 27257416
[TBL] [Abstract][Full Text] [Related]
78. Implications of bladder volume on target coverage and dose to critical structures during high dose rate intracavitary brachytherapy for cervical cancer: A dosimetric study.
Patel RB; Gururajachar JM; Revathy T
J Cancer Res Ther; 2019; 15(6):1207-1211. PubMed ID: 31898648
[TBL] [Abstract][Full Text] [Related]
79. Calculation of dose volume parameters and indices in plan evaluation of HDR interstitial brachytherapy by MUPIT in carcinoma cervix.
Poddar J; Sharma AD; Suryanarayan U; Shah SP; Parikh A; Mehta V; Kumar T
Indian J Cancer; 2018; 55(3):238-241. PubMed ID: 30693886
[TBL] [Abstract][Full Text] [Related]
80. Evaluation of interfractional variation of organs and displacement of catheters during high-dose-rate interstitial brachytherapy for gynecologic malignancies.
Lee S; Rodney E; Traughber B; Biswas T; Colussi V; Podder T
Brachytherapy; 2017; 16(6):1192-1198. PubMed ID: 28993108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
